Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations.
Saved in:
| Title: | Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations. |
|---|---|
| Authors: | McCoull W; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Thomson C; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Braybrooke E; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Chan C; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Colclough N; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Cortés González MA; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden., Cosulich S; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Davies NL; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Floc'h N; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Greenwood R; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Hargreaves D; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Huang P; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Hunt TA; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Johnson T; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Johnström P; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Stockholm SE-171 76, Sweden.; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden., Kettle JG; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Kondrashov M; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden., Kostomiris DH; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Li S; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Lister A; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Martin S; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., McKerrecher D; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., McLean N; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Nissink JWM; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Orme JP; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Orwig P; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Packer MJ; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Pearson S; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Qin L; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Felisberto-Rodrigues C; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Savoca A; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Schou M; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Stockholm SE-171 76, Sweden.; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden., Stokes S; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Swaih AM; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Talbot S; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Tucker MJ; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Ward RA; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Wadforth E; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Wang C; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Wilson J; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China., Yang Y; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2025 Feb 13; Vol. 68 (3), pp. 3700-3748. Date of Electronic Publication: 2025 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39869768 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McCoull+W%22">McCoull W</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Thomson+C%22">Thomson C</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Braybrooke+E%22">Braybrooke E</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Chan+C%22">Chan C</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Colclough+N%22">Colclough N</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Cortés+González+MA%22">Cortés González MA</searchLink>; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Cosulich+S%22">Cosulich S</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Davies+NL%22">Davies NL</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Floc'h+N%22">Floc'h N</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Greenwood+R%22">Greenwood R</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Hargreaves+D%22">Hargreaves D</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Huang+P%22">Huang P</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Hunt+TA%22">Hunt TA</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Johnson+T%22">Johnson T</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Johnström+P%22">Johnström P</searchLink>; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Stockholm SE-171 76, Sweden.; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Kettle+JG%22">Kettle JG</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Kondrashov+M%22">Kondrashov M</searchLink>; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Kostomiris+DH%22">Kostomiris DH</searchLink>; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Lister+A%22">Lister A</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Martin+S%22">Martin S</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22McKerrecher+D%22">McKerrecher D</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22McLean+N%22">McLean N</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Nissink+JWM%22">Nissink JWM</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Orme+JP%22">Orme JP</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Orwig+P%22">Orwig P</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Packer+MJ%22">Packer MJ</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Pearson+S%22">Pearson S</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Qin+L%22">Qin L</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Felisberto-Rodrigues+C%22">Felisberto-Rodrigues C</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Savoca+A%22">Savoca A</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Schou+M%22">Schou M</searchLink>; PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Stockholm SE-171 76, Sweden.; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm SE-171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Stokes+S%22">Stokes S</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Swaih+AM%22">Swaih AM</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Talbot+S%22">Talbot S</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Tucker+MJ%22">Tucker MJ</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Ward+RA%22">Ward RA</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Wadforth+E%22">Wadforth E</searchLink>; AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Wilson+J%22">Wilson J</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2025 Feb 13; Vol. 68 (3), pp. 3700-3748. <i>Date of Electronic Publication: </i>2025 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39869768 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.jmedchem.4c02811 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3700 Titles: – TitleFull: Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McCoull W – PersonEntity: Name: NameFull: Thomson C – PersonEntity: Name: NameFull: Braybrooke E – PersonEntity: Name: NameFull: Chan C – PersonEntity: Name: NameFull: Colclough N – PersonEntity: Name: NameFull: Cortés González MA – PersonEntity: Name: NameFull: Cosulich S – PersonEntity: Name: NameFull: Davies NL – PersonEntity: Name: NameFull: Floc'h N – PersonEntity: Name: NameFull: Greenwood R – PersonEntity: Name: NameFull: Hargreaves D – PersonEntity: Name: NameFull: Huang P – PersonEntity: Name: NameFull: Hunt TA – PersonEntity: Name: NameFull: Johnson T – PersonEntity: Name: NameFull: Johnström P – PersonEntity: Name: NameFull: Kettle JG – PersonEntity: Name: NameFull: Kondrashov M – PersonEntity: Name: NameFull: Kostomiris DH – PersonEntity: Name: NameFull: Li S – PersonEntity: Name: NameFull: Lister A – PersonEntity: Name: NameFull: Martin S – PersonEntity: Name: NameFull: McKerrecher D – PersonEntity: Name: NameFull: McLean N – PersonEntity: Name: NameFull: Nissink JWM – PersonEntity: Name: NameFull: Orme JP – PersonEntity: Name: NameFull: Orwig P – PersonEntity: Name: NameFull: Packer MJ – PersonEntity: Name: NameFull: Pearson S – PersonEntity: Name: NameFull: Qin L – PersonEntity: Name: NameFull: Felisberto-Rodrigues C – PersonEntity: Name: NameFull: Savoca A – PersonEntity: Name: NameFull: Schou M – PersonEntity: Name: NameFull: Stokes S – PersonEntity: Name: NameFull: Swaih AM – PersonEntity: Name: NameFull: Talbot S – PersonEntity: Name: NameFull: Tucker MJ – PersonEntity: Name: NameFull: Ward RA – PersonEntity: Name: NameFull: Wadforth E – PersonEntity: Name: NameFull: Wang C – PersonEntity: Name: NameFull: Wilson J – PersonEntity: Name: NameFull: Yang Y IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 02 Text: 2025 Feb 13 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1520-4804 Numbering: – Type: volume Value: 68 – Type: issue Value: 3 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |